Impact News +++ Ad-hoc News: Mutares SE & Co. KGaA (EQS) +++ MUTARES Aktie -7,54%

FAGRON Aktie

>FAGRON Aktienkurs

21.8 EUR -0.7% (TradegateBSX)

Ask: 21.9 EUR / 150 Stück

Bid: 21.8 EUR / 150 Stück

Tagesumsatz: 1776 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

FAGRON Aktie über LYNX handeln

Intraday

1 Jahr

>FAGRON Performance

1 Woche: +2,3%

1 Monat: -3,1%

3 Monate: +2,8%

6 Monate: +11,1%

1 Jahr: +15,3%

laufendes Jahr: +2,8%

>FAGRON Aktie

Name:

FAGRON N.V. PORT.

Land:

Belgien

Sektor:

Gesundheit

ISIN/ Wkn:

BE0003874915 / A0M103

Symbol/ Ticker:

4A5 (Frankfurt)

Kürzel:

FRA:4A5, ETR:4A5, 4A5:GR

Index:

Webseite:

https://fagron.com/

Profil:

Fagron NV is a publicly traded multinational company governed by Belgian law, specializing in pharmaceutical compounding to enable personalized medicine for hospitals, pharmacies, clinics, and patients worldwide. Headquartered in Rotterdam, Netherlan..
>Volltext..

Marktkapitalisierung:

1571.25 Mio. EUR

Unternehmenswert:

1856.66 Mio. EUR

Umsatz:

966.94 Mio. EUR

EBITDA:

193.39 Mio. EUR

Nettogewinn:

92.43 Mio. EUR

Gewinn je Aktie:

1.26 EUR

Schulden:

475.49 Mio. EUR

Liquide Mittel:

187.77 Mio. EUR

Operativer Cashflow:

130.27 Mio. EUR

Bargeldquote:

0.84

Umsatzwachstum:

9.2%

Gewinnwachstum:

12.99%

Dividende je Aktie:

0.35 EUR

Dividendenrendite:

1.16%

Dividendenschätzung:

1.31%

Div. Historie:

19.05.25 - 0.35€
21.05.24 - 0.3€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

FAGRON

Letzte Datenerhebung:

01.04.26

>FAGRON Kennzahlen

Aktien/ Unternehmen:

Aktien: 73.24 Mio. St.

Frei handelbar: 94.44%

Leerverk. Aktien: -

Rückkaufquote: -0.27%

Mitarbeiter: 4134

Umsatz/Mitarb.: 0.23 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 29.3%

Bewertung:

KGV: 17.36

KGV lG: 14.64

KUV: 1.69

KBV: 2.87

PEG-Ratio: 1.39

EV/EBITDA: 9.6

Rentabilität:

Bruttomarge: 21.5%

Gewinnmarge: 9.56%

Operative Marge: 15.38%

Managementeffizenz:

Gesamtkaprendite: 7.82%

Eigenkaprendite: 17.29%

>FAGRON Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>FAGRON Chart & Kurs - Tradegate

>FAGRON News

31.03.26 - 19:03	Fagron increases share capital through exercise subscription rights (GlobeNewswire EN)
	Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 31 March 2026 – 7PM CET...

17.03.26 - 15:06	Fagron Sterile Services Strengthens U.S. Supply of Sterile Water for Injection Through Project PROTECT Partnership (PR Newswire)
	WICHITA, Kan., March 17, 2026 /PRNewswire/ -- Fagron Sterile Services (FSS) today announced a major milestone in strengthening the nation's supply of critical injectable medicines, with its Sterile Water for Injection (SWFI) production now fully production-ready through the Angels for......

06.03.26 - 07:03	Fagron publishes its Annual Report 2025 (GlobeNewswire EN)
	Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2026 7AM CET...

03.03.26 - 07:03	Fagron completes acquisition of Vepakum (GlobeNewswire EN)
	Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 3 March 2026 – 7:00AM...

26.02.26 - 18:33	Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA (GlobeNewswire EN)
	Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 February 2026 – 6:30PM...

12.02.26 - 10:30	Earnings Call Transkript: Fagron NV meldet starke Performance für H2 2025 (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

12.02.26 - 07:03	Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA (GlobeNewswire EN)
	Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth, 10.9% increase in REBITDA and 13.6% in EPS...

05.02.26 - 07:03	Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary (GlobeNewswire EN)
	Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 5 February 2026...

12.01.26 - 07:03	Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America (GlobeNewswire EN)
	Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 January 2026 – 7:00 AM CET...

06.01.26 - 07:03	Fagron announces the completion of Purifarma (GlobeNewswire EN)
	Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 January 2026 – 7:00 AM CET...

19.12.25 - 07:06	Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone (GlobeNewswire EN)
	Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 – 7:00 AM CET...

24.11.25 - 07:03	Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business (GlobeNewswire EN)
	Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 24 November 2025 – 7:00 AM CET...

14.11.25 - 18:42	Fagron completes share buy-back program (GlobeNewswire EN)
	Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 14 November 2025 – 6PM CET...

07.11.25 - 18:42	Fagron′s share buy-back program: Weekly update (GlobeNewswire EN)
	Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 7 November 2025 – 6PM CET...

31.10.25 - 18:30	Fagron′s share buy-back program: Weekly update (GlobeNewswire EN)
	Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 31 October 2025 – 6PM CET...

24.10.25 - 18:24	Fagron′s share buy-back program: Weekly update (GlobeNewswire EN)
	Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 24 October 2025 – 6PM CET...

17.10.25 - 18:15	Fagron′s share buy-back program: Weekly update (GlobeNewswire EN)
	Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 17 October 2025 – 6PM CET...

09.10.25 - 07:39	Fagron Q3 revenue rises 6.4% to €228 mln as FDA clears Wichita expansion (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

09.10.25 - 07:03	Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook (GlobeNewswire EN)
	Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 October 2025 – 7:00 AM CET...

06.10.25 - 07:03	Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions (GlobeNewswire EN)
	Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 October 2025 – 7:00 AM CET...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Es gibt einen Tag, um geboren zu werden, und einen Tag, um zu sterben. - China Weisheit

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram